Your browser doesn't support javascript.
loading
Rapid Clinical and Radiologic Responses With Larotrectinib Treatment in a Patient With TRK-Fusion-Positive Metastatic Lung Cancer.
Hochmair, Maximilian Johannes; Setinek, Ulrike; Krenbek, Dagmar; Fazekas, Andreas; Illini, Oliver; Weinlinger, Christoph; Draxler, Hermann; Marcher, Markus; Valipour, Arschang; Müllauer, Leonhard; Beer, Lucian.
Afiliação
  • Hochmair MJ; Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Krankenhaus Nord, Vienna, Austria. Electronic address: maximilian.hochmair@wienkav.at.
  • Setinek U; Department of Pathology, Wilhelminenspital, Vienna, Austria.
  • Krenbek D; Department of Pathology, Wilhelminenspital, Vienna, Austria; Department of Pathology, Klinik Floridsdorf, Krankenhaus Nord, Vienna, Austria.
  • Fazekas A; Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Krankenhaus Nord, Vienna, Austria.
  • Illini O; Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Krankenhaus Nord, Vienna, Austria.
  • Weinlinger C; Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Krankenhaus Nord, Vienna, Austria.
  • Draxler H; Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Krankenhaus Nord, Vienna, Austria.
  • Marcher M; Department of Thoracic Surgery, Klinik Floridsdorf, Krankenhaus Nord, Vienna, Austria.
  • Valipour A; Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Krankenhaus Nord, Vienna, Austria.
  • Müllauer L; Institute of Pathology, Medical University of Vienna, Vienna, Austria.
  • Beer L; Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria; Department of Radiology and Cancer Research UK, Cambridge, England, UK.
Clin Lung Cancer ; 21(2): e49-e53, 2020 03.
Article em En | MEDLINE | ID: mdl-31879191
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Proteínas de Fusão Oncogênica / Receptor trkA / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans Idioma: En Revista: Clin Lung Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Proteínas de Fusão Oncogênica / Receptor trkA / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans Idioma: En Revista: Clin Lung Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article